Compass Ion Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Compass Ion Advisors's MRK Position: Q2 2026 in Review
Compass Ion Advisors reduced its Merck (MRK) stake by 2.3% in Q2 2026, selling an estimated $47.9K and leaving 17,384 shares worth $2.23M. The position accounts for 0.19% of the portfolio, ranked #62.
Compass Ion Advisors first reported a position in MRK in Q4 2019 and has held it in 20 quarters since. The position peaked at $3.08M in Q2 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Compass Ion Advisors held 17,384 shares of Merck worth $2.23M as of Q2 2026.
- Compass Ion Advisors sold 409 Merck shares in Q2 2026, an estimated $47.9K.
- Merck made up 0.19% of Compass Ion Advisors's portfolio in Q2 2026, its #62 holding.
- Compass Ion Advisors first reported a position in Merck in Q4 2019 and has held it in 20 quarters since.
- Compass Ion Advisors's Merck position peaked at $3.08M in Q2 2024.
- 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Compass Ion Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.